Fresh Tissue for Advanced Research Applications

Fresh tissue specimens preserve native cellular viability, metabolic activity, and architectural integrity that are lost in fixed or frozen processing, making them essential for translational research applications requiring living cells. MT Group has delivered fresh tissue specimens for over 20 years, supporting diverse research programs. Fresh tissue enables biomarker discovery through functional assays and real-time cellular response measurements, organoid development for therapy screening and disease modeling, ex vivo drug response testing, primary cell isolation for mechanistic studies, single-cell analyses requiring intact viable cells, and tissue explant cultures for studying complex cellular interactions.

Whether you need fresh tumor tissue, normal tissue for comparative analyses, or diseased tissue from autoimmune or inflammatory conditions, MT Group’s expertise ensures specimens maintain viability throughout collection and transport. Our established protocols for rapid procurement, controlled 2-8°C cold-chain shipping, and placement into sponsor-validated tissue media deliver specimens ready for immediate use in functional assays, culture establishment, or advanced cellular characterization technologies.

Request Fresh Tissue Today

Types of Fresh Tissue Available

Tumor Tissue

Fresh tumor tissue from surgical resections and excisions is available across nearly all solid tumor types including lung, breast, colorectal, pancreatic, prostate, renal and many other cancer sites. Tumor specimens can be collected with matched normal adjacent tissue from the same patient to enable direct comparisons between malignant and non-malignant tissue biology. Tissue is procured immediately following surgical removal and placed into transport media to preserve cellular viability during overnight shipment.

Gastrointestinal Biopsies

Fresh GI biopsies from endoscopic and colonoscopic procedures are routinely collected from patients with inflammatory bowel disease, celiac disease, and other gastrointestinal conditions. Both inflamed and non-inflamed mucosal biopsies can be obtained during the same procedure, providing matched diseased and control tissue from individual patients. These small biopsies are ideal for organoid cultures, explant assays, and single-cell studies.

Dermatologic Biopsies

Fresh skin biopsies are regularly collected from patients with psoriasis, atopic dermatitis, vitiligo, and other inflammatory or autoimmune skin conditions. Lesional biopsies from active disease sites and non-lesional biopsies from uninvolved skin can be obtained from the same patient during dermatology procedures. Fresh skin specimens support epidermal and dermal cell isolation, skin explant cultures, and functional studies of barrier function and immune responses.

Normal Skin and Adipose Tissue

Fresh normal skin and subcutaneous adipose tissue are available from healthy donors and surgical patients undergoing elective procedures. These normal tissue specimens provide sources for primary cell isolation including keratinocytes, fibroblasts, adipocytes, and stromal vascular fraction cells for diverse research applications.

Other Fresh Tissue Types

Additional fresh tissue specimens may be available depending on surgical volume at collection sites and specific research requirements. MT Group works with you during feasibility assessment to determine availability for specialized tissue types and rare anatomic sites.

Why Researchers Choose MT Group for Fresh Tissue

Over 20 Years of Fresh Tissue Collection Experience: MT Group has refined fresh tissue collection protocols over more than two decades of supporting pharmaceutical and biotechnology research. Our established standard operating procedures ensure consistent specimen quality, proper handling techniques, and reproducible outcomes across thousands of collections. Sponsors who work with multiple tissue suppliers regularly tell us that MT Group provides tissues with the best cell viability, reflecting our comprehensive approach to fresh tissue procurement.

Temperature-Controlled Overnight Shipping: All fresh tissue specimens are shipped overnight at 2-8°C using shippers certified to maintain the precise temperature control for maximum cellular viability.

Rapid Placement into Optimized Tissue Media: Fresh tissue is rapidly placed into MT Group's proprietary transport media optimized for maximum cell viability. Our transport media has been refined over two decades. In head-to-head comparison studies conducted with sponsors, researchers consistently select MT Group's media over historically preferred media due to superior cell recovery and viability.

Proven Site Network and Quality Systems: Our collection sites follow MT Group's detailed protocols with precision, understanding that fresh tissue collections require exacting standards. Sites are trained on proper tissue handling, rapid processing workflows, and quality control measures that preserve the functional characteristics essential for translational research.

Quality Assurance & Services

Ethical procurement, rigorous reviews and full traceability ensure specimens you can trust.

IRB‑Approved Collections

All MT Group tissue collections are conducted under Institutional Review Board (IRB) approval, ensuring ethical procurement and full regulatory compliance. This commitment guarantees that every specimen is collected with proper informed consent and adheres to the highest standards of human subject research protections.

Clinical Data Validation

MT Group maintains a dedicated clinical data team that meticulously reviews all case report forms from collection sites for completeness and internal consistency before resolving any discrepancies found with the clinical site. We understand how critical this data is to research; nearly any information collected as part of standard clinical care is routinely captured and non-standard-of-care data collection can often be arranged to meet specific study requirements.

Specimen Replacement Guarantee

MT Group stands behind the quality of every specimen delivered. If any tissue fails to meet specifications due to shipping issues, handling concerns, or quality parameters, we will replace the specimen at no additional cost, ensuring your research timelines and budgets remain on track.

Chain of Custody & Documentation

Comprehensive documentation accompanies each specimen, including collection details, processing protocols, storage conditions, and pathology reports. This complete chain of custody provides full traceability and the clinical context necessary for robust, reproducible research outcomes.

Why Leading Researchers Choose MT Group

"MT Group's clinical expertise during the study design phase was exceptional. Their team brings valuable insights that strengthen our collection protocols and their exhaustive attention to detail ensures nothing is overlooked. This combination of scientific knowledge and meticulous planning has been instrumental in building powerful prospective tissue collections that meet our research objectives."

— Senior Scientist, Top 10 Biopharmaceutical Company

"The communication has been stellar throughout our collaboration. The weekly study updates keep us fully informed, and the detailed collection notification emails make accessioning samples extremely easy for our lab partners. The project management team is responsive and proactive—it's exactly what we need to keep our studies running smoothly."

— Business Operations Manager, Liquid Biopsy Company

"We've noticed a decline in FFPE block quality across the market in recent months but MT Group has consistently delivered the highest quality specimens. Their rigorous quality control and pathologist review process ensures we receive blocks that meet our exact specifications. In a challenging supply environment, that reliability is invaluable."

— Research Scientist, Global Biopharmaceutical Company

"MT Group's responsiveness and flexibility have been exceptional. They consistently delivered rare, high-quality samples that were essential to our research, with impeccable service and follow-up at every step. Their ability to source difficult-to-find specimens and their quick attention to every inquiry made all the difference for our program. We're deeply grateful for their partnership."

— CEO, Cell Therapy Company

"The prospective collections were much smoother than our previous vendor experiences. MT Group's thorough feasibility assessments and consistent follow-ups throughout the collection process gave us confidence and clarity at every stage. It's refreshing to work with a partner who is this proactive and organized."

— Senior Clinical Study Lead, Research Tools Company

Frequently Asked Questions

What is the typical turnaround time from surgery to delivery?

Fresh tissue is collected during surgical procedures, rapidly processed and placed into transport media, and shipped overnight at 2-8°C for next-day delivery. From the time of surgical resection to arrival at your facility is typically 18-24 hours, ensuring specimens maintain cellular viability for immediate downstream applications.

Can I receive tissue in my own transport media?

While MT Group's proprietary transport media consistently delivers superior cell viability as demonstrated in head-to-head comparisons, we understand some protocols may require specific media formulations. However, using alternative media requires providing those reagents to our collection sites, which adds logistical complexity. We recommend discussing media requirements with your business development contact to determine the best approach for your application.

What size tissue specimens can be provided?

Tissue specimen size depends on the surgical procedure and anatomic site. Tumor resections typically provide 200mg or more although some resections can yield substantially more tissue. Skin biopsies are either 2mm or 3-4mm in diameter depending on the biopsy instrument used. Colonic biopsies are "pinch" biopsies obtained during endoscopic procedures. MT Group conducts feasibility assessments to ensure tissue quantity expectations align with what procedures can reliably deliver.

Can matched tumor and normal adjacent tissue be collected?

Yes, matched tumor tissue and normal adjacent tissue from the same patient can be collected during tumor resection procedures. This paired sampling enables direct comparisons between malignant and non-malignant tissue from the same individual, controlling for patient-specific genetic and environmental factors.

What happens if there is a shipping delay or delivery issue?

If a courier or FedEx delivery delay results in tissue that is not viable for your research applications, you are not charged for that specimen. MT Group stands behind the quality of delivered specimens and only invoices for tissue that meets your viability requirements.

What documentation accompanies fresh tissue specimens?

Fresh tissue specimens are accompanied by comprehensive clinical documentation including patient demographics, diagnosis, disease stage, treatment history, and a surgical pathology report or summary.

Can fresh tissue be collected internationally?

Fresh tissue requiring overnight delivery at 2-8°C can only be collected and shipped to US locations as logistics constraints and customs clearance timelines would compromise viability. International tissue collections are feasible for frozen or FFPE specimens that tolerate longer transit times.

How do you handle situations where surgical procedures are cancelled or patients don't qualify?

Scheduled collections can be cancelled if a patient doesn’t show for the procedure, doesn't sign the consent form, or if the resected tumor is too small or necrotic to be released by pathology for research use. When this occurs, MT Group works to identify and enroll other qualifying subjects to maintain study timelines and meet enrollment targets.

Contact MT Group

Complete the form below to discuss your tissue requirements with our experts.
No obligation consultation. Response within one business day.